Chiara Farroni
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Type 2 Diabetes Reshapes the B-Cell Compartment in Tuberculosis, with Reduction of Transitional B Cells and Expansion of Plasmablasts.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 27, 2026
Host-pathogen interaction in community-acquired pneumonia: a focus on the immune response.
Journal: Frontiers in cellular and infection microbiology
Published: October 27, 2025
3-Gene-TB-SCORE Accuracy for Tuberculosis Disease Diagnosis Is Not Affected by Immune-Mediated Inflammatory Disease Comorbidity.
Journal: International journal of molecular sciences
Published: September 03, 2025
Specific immune response to M. tuberculosis and ability to in vitro control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection.
Journal: Frontiers in immunology
Published: August 21, 2024
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis.
Journal: Frontiers in immunology
Published: April 03, 2024
Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 25, 2024
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report.
Journal: Frontiers in oncology
Published: September 07, 2023
Persistently active interferon-γ pathway and expansion of T-bet+ B cells in a subset of patients with childhood-onset systemic lupus erythematosus.
Journal: European journal of immunology
Published: December 06, 2022
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 19, 2022
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 12, 2022
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.
Journal: Frontiers in immunology
Published: July 01, 2022
Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis.
Journal: Frontiers in neurology
Published: February 23, 2022
Last Updated: 09/26/2026